Login
|
Register
News
Videos
Insights
Peer Exchange
OncNurse TV
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Hematology
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Chemotherapy Safety
Skin Cancer/Melanoma
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Genetics
How to Advise Patients About Direct-to-Consumer Genetic Testing
BY SUZANNE M. MAHON, RN, DNSC, AOCN, AGN-BC
Counseling by Oncologists Could Shorten BRCA Testing Time for Ovarian Cancer
BY JASON HARRIS
Surprise, You Are Adopted
BY SUZANNE M. MAHON, RN, DNSC, AOCN, AGN-BC
Benefits and Risks of Direct to Consumer Genetic Testing for Cancer
BY SUZANNE M. MAHON RN, DNSC, AOCN, AGN-BC
FDA Approves Olaparib, a PARP Inhibitor, for BRCA+ Breast Cancer
BY JASON M. BRODERICK
Investigating the Use of Olaparib and Durvalumab in BRCA-mutant Breast Cancer Treatment
BY SILAS INMAN
Megan Hoffman on the Importance of Nurses Understanding Genomics
BY MEGAN HOFFMAN, MSN, RN, CMSRN, AOCNS
For Women With BRCA Mutations, Who Is Most at Risk of Breast and Ovarian Cancer?
BY KATIE KOSKO
Megan Hoffman on Adding the Nurse's Voice to Pharmacogenomics
BY MEGAN HOFFMAN, MSN, RN, CMSRN, AOCNS
Krista Qualmann on Genetic Counseling and Testing for Patients with Cancer
BY KRISTA QUALMANN, MS, CGC
<< Prev Page
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.